Search

Your search keyword '"Ceci, F."' showing total 49 results

Search Constraints

Start Over You searched for: Author "Ceci, F." Remove constraint Author: "Ceci, F." Publisher elsevier bv Remove constraint Publisher: elsevier bv
49 results on '"Ceci, F."'

Search Results

1. PSMA-PET vs. conventional imaging for preoperative staging high-risk PCa patients underwent surgery for cN0M0 disease

2. Second line PSMA-targeted salvage treatment in patients with mi N1/M1a-b oligorecurrent PCa

5. Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on PSMA-PET: Results of a Multicenter, European Study

6. Does metastases-direct therapy guided by PSMA PET/CT really improve oncologic outcomes in oligorecurrent prostate cancer patients?

7. The impact of PSMA PET/CT on oncologic outcomes of patients with recurrent prostate cancer: The experience of 3 high-volume European centers

8. The Maximum Standardized Uptake Value in Patients with Recurrent or Persistent Prostate Cancer after Radical Prostatectomy and PSMA-PET-Guided Salvage Radiotherapy – A Multicenter Retrospective Analysis

9. The impact of PSMA PET/CT on oncologic outcomes of patients with recurrent prostate cancer: the experience of 3 high-volume european centers

10. Does metastases-direct therapy guided by PSMA PET/CT really improve oncologic outcomes in oligorecurrent prostate cancer patients?

11. Event-Free survival after 68Ga-PSMA-11 PET/CT in recurrent Hormone-Sensitive Prostate Cancer (HSPC) patients eligible for salvage therapy

12. Oncological outcomes in patients with recurrent prostate cancer staged with PSMA PET/CT: Results from 3 European tertiary centers

15. Metastasis-free survival after salvage radiotherapy for post-operative prostate cancer patients in the PSMA PET/CT era – a multicenter analysis

16. External validation of a nomogram for predicting 68GA-PSMA PET/CT detection rate in patients with prostate cancer recurrence: a clinical tool to guide physicians before suggesting 68GA-PSMA PET/CT

17. PO-1335 PSMA-PET impact on post-prostatectomy recurrencies multidisciplinary management: focus on RT

18. The impact of ANGPTL3 deficiency on hepatic steatosis: Observations from carriers of loss-of-function mutations

20. Evaluating the predictive accuracy and the clinical benefit of a nomogram aimed to predict 68Ga-labeled Prostate-Specific Membrane Antigen-Ligand Positron-Emission Tomography/Computer Tomography positivity in patients with biochemical recurrent prostate

21. Which patient with biochemical recurrence after primary treatment for prostate cancer would result in a positive 68Ga-PSMA PET/CT? A clinical tool to guide physicians before suggesting 68Ga-PSMA PET/CT

24. How does 68Ga-PSMA PET/CT impact the treatment management in patients with prostate cancer recurrence after surgery?

25. 68Ga-PSMA PET/CT Mapping of Prostate Cancer at Initial Staging: Potential Impact on Definitive Radiation Therapy Planning

26. Clinical impact of 68Ga-PSMA PET/CT on the management of patients experiencing biochemical recurrence after radical prostatectomy

27. 68Ga-PSMA PET/CT in patients with biochemical recurrence after radical prostatectomy: How to predict a positive PSMA PET/CT results and the site of recurrence

28. 68Ga-PSMA PET/CT in biochemical recurrence after a radical treatment for prostate cancer: Detection rate and comparison with conventional imaging and choline PET/CT

30. 68 Ga-PSMA PET/CT in prostate cancer

31. La PET/TC con 68 Ga-PSMA en el cáncer de próstata

34. 821 Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up

35. PET/CT in prostate cancer

36. 727 18F-FACBC PET/CT in comparison to 11c-choline for the detection of prostate cancer relapse after radical prostatectomy: A perspective study in 50 patients

38. Expression and DNA methylation of ENaC genes

47. Amino acids and hepatic encephalopathy

48. Imaging of Prostate Cancer Using 11 C-Choline PET/Computed Tomography

49. Diagnostic imaging work-up for disease relapse after radical treatment for prostate cancer: How to differentiate local from systemic disease? The urologist point of view

Catalog

Books, media, physical & digital resources